Clinical Trial Update: Comparison of HR011408 and NovoRapid® in Subjects With Diabetics [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating HR011408 versus NovoRapid in adults with diabetes and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• HR011408
• NovoRapid (insulin aspart)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Diabetes | Phase 1 | Status: RECRUITING